BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
21.71
-0.56 (-2.51%)
At close: Mar 2, 2026, 4:00 PM EST
21.62
-0.09 (-0.41%)
After-hours: Mar 2, 2026, 6:05 PM EST
BioAge Labs Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for BioAge Labs stock have an average target of 44.4, with a low estimate of 12 and a high estimate of 73. The average target predicts an increase of 104.51% from the current stock price of 21.71.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioAge Labs stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Hold | 3 | 2 | 2 | 3 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $60 | Buy | Initiates | $60 | +176.37% | Feb 25, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $9 → $62 | Hold → Strong Buy | Upgrades | $9 → $62 | +185.58% | Feb 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $73 | Buy | Initiates | $73 | +236.25% | Jan 27, 2026 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $5 → $12 | Sell → Hold | Upgrades | $5 → $12 | -44.73% | Dec 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | -30.91% | Oct 29, 2025 |
Financial Forecast
Revenue This Year
7.02M
Revenue Next Year
2.94M
from 7.02M
Decreased by -58.12%
EPS This Year
-2.34
from -6.63
EPS Next Year
-2.96
from -2.34
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.4M | 8.8M | ||||
| Avg | 7.0M | 2.9M | ||||
| Low | 5.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 25.7% | ||||
| Avg | - | -58.1% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.16 | -2.78 | |||
| Avg | -2.34 | -2.96 | |||
| Low | -2.74 | -3.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.